Beam Therapeutics BEAM
NASDAQ BEAM
$25.15 -1.87 (-6.92%)
At close: Nov 10, 2026 · 4:00 PM EST

Beam Therapeutics (BEAM) Long-Term Investments (2020 - 2021)

Updated

Beam Therapeutics (BEAM) reported Long-Term Investments of $24.54 million for Q3 2021, down 16.6% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Long-Term Investments (2020 - 2021) Analysis & Trends

At the end of FY2020, Beam Therapeutics posted Long-Term Investments of $2.58 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Beam Therapeutics 2.60 Bn -2.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 24.54 Mn
Jun 30, 2021 29.43 Mn
Dec 31, 2020 2.58 Mn
API Access

Beam Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=BEAM&period=max&api_key=YOUR_API_KEY